This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Repros Therapeutics Inc (RPRX)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 75.81M 24.21M 4.56M 2.96M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 76.00M 24.62M 4.66M 3.28M
Property, Plant & Equipment, Gross 216.00K 154.00K 123.00K 109.00K
Accumulated Depreciation & Depletion 141.00K 101.00K 108.00K 102.00K
Property, Plant & Equipment, Net 75.00K 53.00K 15.00K 7.00K
Intangibles 2.91M 0.00 0.00 0.00
Other Non-Current Assets 0.00 2.16M 1.38M 1.17M
Total Non-Current Assets 2.98M 2.21M 1.40M 1.18M
Liabilities & Shareholder Equity
Total Assets 78.98M 26.83M 6.06M 4.46M
Accounts Payable 2.97M 3.24M 1.14M 1.15M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 3.55M 3.80M 1.40M 1.30M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 0.00 0.00 0.00 0.00
Total Liabilities 3.55M 3.80M 1.40M 1.30M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 75.42M 23.03M 4.67M 3.17M
Common Par 23.00K 17.00K 12.00K 9.00K
Additional Paid In Capital 314.40M 234.30M 197.77M 183.78M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -237.62M -209.90M -191.74M -179.24M
Treasury Stock -1.38M -1.38M -1.38M -1.38M
Other Equity Adjustments 0.00 0.00 0.00 0.00
Total Capitalization 75.42M 23.03M 4.67M 3.17M
Total Equity 75.42M 23.03M 4.67M 3.17M
Total Liabilities & Stock Equity 78.98M 26.83M 6.06M 4.46M
Total Common Shares Outstanding 23.01M 17.16M 12.36M 8.93M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 112.35K 112.35K 112.35K 112.35K
Basic Weighted Shares Outstanding 20.81M 15.35M 11.96M 8.06M
Diluted Weighted Shares Outstanding 20.81M 15.35M 11.96M 8.06M
Number of Employees 25 21 13 6
Number of Part-Time Employees 0 0 0 0
RPRX News

RPRX Repros Therapeutics Inc

Analysts Ratings for RPRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET RPRX ANALYST REPORT

Brokerage Partners

RPRX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs